No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Financial - Conglomerates
KDventures AB is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, medical innovations, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. The company was formerly known as Karolinska Development AB (publ) and change its name to KDventures AB in February 2026. KDventures AB was founded in 2003 and is headquartered in Solna, Sweden.
www.karolinskadevelopment.comNo one on the platform currently holds KDEV.ST.
No tracked institution reports a position in KDEV.ST as of their last filing.
No one on the platform has traded KDEV.ST yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2M | +0.0% | $-0.10 | $-0.10–$-0.10 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| KDEV.STKarolinska Development AB (publ) | $0.26 | -2.07% | $70M | — |
| ALZCUR.STAlzeCure Pharma AB | $7.96 | -0.50% | $1.0B | — |
| ANNX.STAnnexin Pharmaceuticals AB | $12.80 | +0.79% | $92M | — |
| BIOWKS.STBio-Works Technologies AB (publ) | $3.21 | +1.90% | $266M | — |
| BOUL.STBoule Diagnostics AB | $2.58 | -0.00% | $100M | — |
| INIT.STInitiator Pharma A/S | $2.20 | -3.93% | $151M | — |
| IRLAB-A.STIRLAB Therapeutics AB (publ) | $1.84 | +0.33% | $269M | — |
Source: Financial Modeling Prep · peers by sector/industry